Treatment Intensity for the Management of Cardiogenic Shock
Shashank S. Sinha(Inova Fairfax Hospital), Navin K. Kapur(Tufts Medical Center), Maya Guglin(Indiana University Health), Claudius Mahr(Medical City Dallas Hospital), Van‐Khue Ton(Massachusetts General Hospital), Arvind Bhimaraj(Houston Methodist), Jeffrey A. Marbach(Tufts Medical Center), A.R. Garan(Beth Israel Deaconess Medical Center), Adnan Khalif(Allegheny Health Network), Rachna Kataria(Massachusetts General Hospital), Jaime Hernández-Montfort(Baylor Scott & White Health), Katherine Thayer(Tufts Medical Center), Daniel Burkhoff(Columbia University Irving Medical Center), Song Li(University of Pittsburgh), Wissam Khalife(The University of Texas Medical Branch at Galveston), Andrew Schwartzman(Maine Medical Center), Mohit Pahuja, Manreet Kanwar(University of Chicago), Esther Vorovich(Northwestern University), Haroon Faraz(Hackensack Meridian Health), Paulina Baca(Tufts Medical Center), Jacob Abraham(Providence St. Vincent Medical Center), Detlef Wencker(Baylor Scott & White Health), Sandeep Nathan(University of Chicago), Saraschandra Vallabhajosyula, Ju H. Kim(Houston Methodist), Vanessa Blumer(Massachusetts General Hospital), Anthony J. Faugno(Tufts Medical Center), Gavin Hickey(University of Pittsburgh Medical Center), Fatou Dieng(Tufts Medical Center), Neil Harwani(Tufts Medical Center), Yijing Zhang(Donghua University), Borui Li(Tufts Medical Center), Michael Yaoyao Yin(University of Utah), Shelley Hall
Cited by 17
Related Papers
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
|Nature Medicine|2021|599
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
|JAMA Internal Medicine|2020|555
Criteria for Defining Stages of Cardiogenic Shock Severity
|Journal of the American College of Cardiology|2022|283
The continuous heart failure spectrum: moving beyond an ejection fraction classification
|European Heart Journal|2019|258